Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Recalcitrant Alopecia Totalis and Universalis
NCT00997815Phase 3Completed
- Sponsor
- Siriraj Hospital
- Start
- Dec 2009
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alopecia totalis (AT) and alopecia universalis (AU) comparing Botulinum toxin A with Placebo (2 arms). Primary endpoint: Percentage of terminal hair regrowth at 4 months. Started Dec 2009; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
alopecia totalis (AT)alopecia universalis (AU)
Beyond the preview
Go deeper on NCT00997815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00997815.